Introduction
As the field of tissue engineering (TE) matures, the need for novel techniques to characterize engineered constructs (i.e. cells/tissue combined with scaffolds) in a more insightful and quantitative manner becomes imperative. Currently, standard techniques such as histological sectioning and Live/Dead viability/cytotoxicity staining show limited potential as quality controls for TE constructs as these techniques only allow assessment of tissue distribution in two dimensions, with loss of information and with limited depth resolution while being destructive in nature. (1) (2) (3) (4) Techniques such as confocal microscopy may offer a potential for three dimensional (3D) visualization, however again a limited depth resolution (~300 µm) hinders their performance when larger TE construct need to be analyzed. (5) Recent advances in 3D imaging techniques and image analysis strategies have demonstrated the potential of addressing some of the shortfalls of these currently applied methods for accurate TE construct analysis. In particular X-ray microfocus computed tomography (microCT) has been frequently applied as a 3D quantitative imaging technique to assess scaffold structure, (6) (7) (8) as well as bone ingrowth after in vivo implantation. (6, (9) (10) (11) (12) (13) (14) Furthermore it has been employed for time-lapsed follow-up of mineralization inside scaffolds during in vitro static (15) (16) (17) or bioreactor cultures. (13, 18, 19) In most of these studies polymeric, ceramic, collagen scaffolds or composites were used, in which mineralized extracellular matrix (ECM) could be separated from the scaffold for the purpose of volume calculations and no significant material-dependent artifacts were present. However, when imaging ECM or tissue growth in metallic scaffolds or around implants, additional caution has to be taken during image analysis as metal artifacts (20, 21) can significantly influence the accuracy of the quantification of the newly formed ECM or tissue volume. (22, 23) Several studies have shown that when using phase contrast imaging, in most cases only available by synchrotron radiation, non-mineralized ECM formed in vitro in 3D TE constructs can be visualized. (24) (25) (26) However, routine access to systems allowing phase contrast imaging is limited and there are restrictions on the sample specifications. On the other hand, by using the more routinely available desktop microCT in standard absorption mode, without the use of a contrast agent, it has not been possible yet to visualize in vitro produced non-mineralized ECM in 3D scaffolds. (24, 27) To address this limitation osmium tetroxide, (28) a well-known X-ray opaque staining, has been used to visualize cells in 3D
constructs. This stain is however toxic to cells, thus cannot be used for non-invasive quality control of ECM growth in the TE construct.
In this study, we propose contrast enhanced nanofocus CT (CE-nanoCT), (29) as a 3D imaging technique that combines the high spatial and contrast resolution of nanoCT with the use of contrast agents, to characterize engineered ECM in TE constructs after in vitro culture.
In particular we performed a 3D quantitative and qualitative structural and spatial assessment of the in vitro engineered ECM, formed during static and bioreactor cell culturing in titanium alloy scaffolds. By using metallic scaffolds in this case study we additionally proved the effectiveness of CE-nanoCT, as these scaffold types represent the worst case scenario with regard to material-dependent image artifacts. The two selected tissue-specific contrast agents that were used to stain the TE construct after culture were Hexabrix ® and phosphotungstic acid (PTA). The latter is known to bind to connective tissues, and more specifically to collagen and fibrin. (30) The former contains a negatively charged ioxaglate, which will be locally repulsed by the negative fixed charge density of the tissue, thus all tissues which do not contain a negative charge will be stained. (31, 32) Additionally, Hexabrix ® has been used for in vivo animal studies (33) and in a clinical setting, (34) and thus is a potential candidate for non-invasive TE construct quality assessment. To evaluate the potential of CE-nanoCT for 3D visualization and quantification of in vitro engineered ECM by culture of human periosteum derived cells (hPDCS, i.e. a cell type that has been seen to be mulitpotent and to contribute in bone regeneration (35, 36) ) in 3D titanium alloy scaffolds, a comparison was made to routine physical measurement techniques, such as Live/Dead viability/cytotoxicity for cell viability, picrosirius red staining for collagen content and ECM weight measurements.
Materials and Methods

Ti6Al4V scaffolds
3D additive manufactured open porous Ti6Al4V scaffolds (subsequently referred to as
Ti scaffolds: Ø = 6 mm, h = 6 mm, porosity = 73 ± 1%, strut diameter = 245 ± 2 µm and pore size = 755 ± 3 µm), produced on an in-house developed selective laser melting (SLM) machine, (37) were used. The design was based on a parametric unit cell (FIG. 1A) , which consists entirely of identical beams with constant circular cross-section (0.1 mm) and a beam length of 0.9 mm. Figure 1B visualizes connected to a peristaltic pump (IPC-24, Ismatec SA). Two different perfusion flow rates were used for the bioreactor culture: the low flow rate used was 0.04 ml/min while the high flow rate was 4 ml/min. In both static and bioreactor cultures medium was refreshed every two days for the entire culture duration. PTA is a soft tissue contrast agent containing tungsten, which confers strong X-ray contrast when attached to biological tissue, and has a strong binding affinity to fibrin and collagen. Hence PTA is a very useful contrast agent to specifically visualize the collagen and 
CE-nanoCT
3D visualization, and image processing and analysis
For 3D visualization of the TE constructs, CTVox (Bruker micro-CT) was used. For image processing and quantification of the ECM volume in the TE constructs we used CTAn (Bruker micro-CT) according to the scheme in FIG. 2. At first the reconstructed dataset of the entire TE construct was fragmented in different subsets with a similar amount of metallic artifacts (step 1). By using a 3-level automatic Otsu segmentation algorithm (40) on the individual 2D slices, the ECM was separated from both the scaffold and the background, the latter including noise and metal artifacts (step 2). As a result, grey-scale images with distinct grey-scale values for scaffold, ECM and background were generated for the different subsets.
A global threshold was then chosen manually to select the ECM (step 3). In order to reduce the errors introduced by the partial volume effect and metallic artifacts for analyzing the ECM volume, the binarized images for the Ti structure were dilatated by 2 voxels and subtracted from the dataset of binarized ECM images (step 4). The noise was minimized by removing black speckle noise smaller than 500 voxels and white speckle noise smaller than 2000 voxels. In order to solidify the resulting structure, a 'closing' operation (~ 2 voxels) was performed on the resulting images (step 4), providing images suitable for the 3D analysis of the ECM volume. Finally, the ECM volume in the TE constructs was analyzed by performing a 3D analysis on the binarized and processed images (step 5).
Physical characterization of TE constructs for comparison to the CE-nanoCT data
In order to gain further understanding on the properties of the cultured TE constructs, subsequent experimental analyses were performed, as described in this section. They were also used to evaluate the potential of CE-nanoCT and assess the levels of complementarity between established analyses and the suggested imaging technique.
Cell viability by Live/Dead viability/cytotoxicity staining
The cell viability in the TE constructs was evaluated using Live-Dead viability/cytotoxicity staining (Invitrogen, USA). Constructs were rinsed with 1ml PBS, incubated in the staining solution (0.5µl Calcein AM and 2µl Ethidium Homodimer in 1ml PBS) for 20 min under normal cell culture conditions and finally imaged using a Leica M165
FC microscope (38).
Collagen content by picrosirius red staining
The collagen-containing ECM production on the TE constructs was characterized by picrosirius red staining (1mg/mL Sirius Red in saturated Picric acid). (41) The stained samples were thoroughly washed with distilled water to remove unbound dye and dried at 37 o C before qualitative analysis by stereomicroscopy. For quantitative analysis, the picrosirius red dye was dissolved in 0.2M NaOH/Methanol (1:1 ratio) with mild shaking overnight, and the optical density was measured at 492nm using a microplate reader (TECAN) for 1 ml triplicate samples for each condition.
ECM weight measurement
The liquid in the TE constructs was carefully removed using vacuum after which they were dried overnight in 37 o C and subsequently weighed on a high accuracy balance (Sartorius CPA225D). Ti scaffolds were cleansed ultrasonically, immersed for 10 min in acetone, 10 min in ethanol 70%, and 10 min in distilled water, subsequently an alkali treatment was applied for 24 h at 60°C in a 5 M sodium hydroxide (Sigma-Aldrich) solution, samples were rinsed with distilled water, and finally sterilized in a steam autoclave The weight of the cleansed Ti scaffold was subtracted from the total weight, resulting in the net ECM weight.
Results
CE-nanoCT allows 3D visualization of ECM in TE constructs
As a first step in this study TE constructs were scanned with nanoCT without the use of contrast agents. It allowed a visual inspection of 3D hPDC-driven ECM formation in the TE constructs after static or dynamic in vitro culture. However the reconstructed 2D slices (FIG. 3A) were of low image quality (i.e. low contrast between ECM and background) making accurate qualitative evaluation and further 3D quantification impossible. When using Hexabrix ® and PTA, both contrast agents respectively infiltrated and bonded to the ECM, resulting in an increase in 3D grey-scale intensity of the ECM for static (FIG. 3B) as well as for both (low and high flow rate) bioreactor culture derived TE constructs (FIGs. 3C and 3D).
Black arrows in the image indicate ECM boundaries within the TE construct. The high contrast difference between ECM, background and Ti scaffold allowed further processing of the raw CE-nanoCT images.
Live/dead viability/cytotoxicity staining was employed as a benchmark analysis of cell viability and distribution on the different TE constructs. The fluorescent images showed that cells were distributed over the entire outer TE construct surface, indicating similar results for all 3 culture conditions (FIG. 4A) . However CE-nanoCT images of the same TE constructs
showed that for static culture, ECM was only formed at the scaffold periphery, resulting in only partially ECM filled TE constructs, while in the bioreactor cultured TE constructs ECM was also found back throughout the internal TE construct volume (FIG. 4B) .
The cross-sectional CE-nanoCT images were subsequently binarized and processed as 
CE-nanoCT allows 3D quantification of ECM volume in TE constructs
Image analysis of the binarized CE-nanoCT slices for the different contrast agents allowed to quantify the total amount of stained ECM formed within the available void volume (i.e. total TE construct volume excluding the volume of Ti scaffold) for the bioreactor perfusion culture conditions, which was not possible for statically cultured TE constructs as the amount of ECM formed was too small to be quantified. In order to comprehend the CEnanoCT-based ECM characterization in the TE constructs, a comparison was made to two established methods for ECM assessment, namely picrosirius red staining to measure the collagen content and ECM dry weight measurement (FIG. 5 and FIG. 6 (FIG. 5B) because of the binding specificity of PTA to proteins and collagen. Indeed, both FIGs 5B and 6B show that a part of the ECM was not stained by PTA, and that this part was more pronounced for the lower ECM content conditions (seen for the low flow rate).
CE-nanoCT allows spatial visualization and quantification of the ECM in TE constructs
FIGs 7B and 7C show typical 3D renderings of the CE-nanoCT images (both for Hexabrix ® and PTA staining respectively) for a bioreactor perfusion cultured TE construct at high flow rate, together with the corresponding Live/Dead viability/cytotoxicity staining (FIG. 7A) and picrosirius red staining (FIG. 7D) 
Discussion
In order to successfully implement TE constructs as part of a clinical therapy, it is necessary to develop quality control tools that will ensure accurate and consistent TE construct release specifications. (42) In general a substantial amount of routine lab techniques currently used in TE were initially developed and optimized for 2D analysis of cell growth, distribution and matrix secretion in culture flasks and not for use in a 3D setting such as TE constructs (Table 1) . For example the information obtained by destructive scanning electron microscopy (SEM) remains 2D and rather elusive even when multiple sample slices are analyzed. (8, 25, 27) Thus one has to be careful when using 2D validated techniques to draw 3D conclusions. Proper validation under 3D conditions and/or complementary use of additional real 3D information requires substantial additional research, but it is a much safer route to obtain reliable information of 3D cell and tissue behavior. Hence advanced 3D methods to, preferably non-invasively, monitor TE construct properties need to be further developed.
X-ray micro and nanoCT offer a potential solution because of their non-destructive 3D character. However, the value of X-ray CT-based information for TE will ultimately be a trade-off of factors such as physicochemical, morphological and dimensional TE construct properties, contrast enhanced agent and equipment limitations ( Table 2 ). According to specific study objectives, a customized strategy will be required to extract the necessary information in a robust way, ranging from (i) accurate and detailed (100s of µm scale) identification and quantification of different TE construct components limited to small TE construct samples and using phase contrast imaging, (25) constructs based on microCT analysis. Additionally they also reported that mineralized matrix formation was initiated at the scaffold periphery and progressed towards the scaffold center over a period of 44 days. These dynamics may be attributed to fluid flow and convective nutrient and oxygen transport throughout the TE construct volume during culture. (43) (44) (45) In this study CE-nanoCT revealed a dramatic increase of ECM content for bioreactor cultured TE constructs (up to 75% of void volume) with respect to the statically cultured ones (less than 4% of void volume). The low ECM quantity in the static culture case was below the CEnanoCT threshold for ECM quantification, which in this study was determined to be an ECM volume lower than 4% of the total Ti scaffold void volume (FIG. 4) . This lower quantification limit was directly related to the artifacts introduced by the metallic scaffolds used in this work. (46) For other scaffold materials however, it is anticipated that the lower quantification threshold of CE-nanoCT will further decrease, since material-dependent artifacts will be reduced compared to the worst case scenario described here. CE-nanoCT results were then compared to known physical ECM characterization methods, such as dry net weight as a global ECM related parameter and picrosirius red staining as a collagen specific assay, to comprehend the CE-nanoCT data and hence evaluate the potential of CE-nanoCT for 3D ECM quantification in TE constructs. In FIG. 6A , the relative ECM void volume filling obtained via Hexabrix® staining (an equilibrium contrast agent, thus it does not bind to the ECM) was correlated to the net dry weight, resulting in a linear correlation for both flow rates, suggesting that Hexabrix® stains most of the ECM in a quantitative manner. However when using the more tissue-specific contrast agent PTA, which is known to bind to various proteins and connective tissue, (47, 48) a difference with Hexabrix® staining was found (FIG. 5B) , while when comparing to the net dry weight, it was shown that PTA only stained a fraction of the ECM (FIG. 6B) . for both PTA and Hexabrix® stains. It can be observed that TE constructs cultured under high flow rate showed a larger fraction of the ECM stained by PTA, which could be explained as an ECM richer in protein components (on which PTA may specifically bind). Fluid flow is known to enhance matrix synthesis within TE constructs during perfusion culture. (19, 44, 49) Furthermore differences in fibrillar collagen organization of the ECM, which are flow dependent, (50) could also explain the ECM differences that were observed by PTA staining as the ECM morphology could influence the binding mechanism of PTA to the ECM proteins.
In FIG. 5 , it may also be observed that the difference in collagen content, as determined by picrosirius red staining, for the different flow rates is less pronounced than the one observed with the PTA staining. However one has to keep in mind that the picrosirius red staining was used without any customization and validation for the specifics of the 3D environment under investigation, which could underestimate actual collagen content. (FIG. 4) . A potential validation technique could be histological sectioning. However, the use of Ti scaffolds in this work does not allow the sectioning of the produced TE constructs, and thus will also not present full 3D data.
To conclude, for the combination of factors used in this work, i.e. scaffold size and material type, type of CT device and scanning mode (Table 2) , and its objective, CE-nanoCT has shown potential as a cost effective TE construct quality control methodology, by providing volumetric and distribution measurements throughout the entire TE construct (FIGs 7 and 8). Although there are preliminary indications for ECM composition analysis via this method which need to be further investigated, the novel information that CE-nanoCT generates will assist to increase our insight in the ECM characteristics within in vitro manufactured TE constructs. In this study we showed proof of concept for CE-nanoCT as a 'whole-construct' imaging technique with non-invasive potential that enables 3D visualization and quantification of in vitro engineered ECM in TE constructs. The development of robust tools and methodologies such as CE-nanoCT to assess important and potentially critical quality characteristics of TE constructs such as ECM quantity and homogeneity, can facilitate the gradual transformation of 'TE constructs' to well characterized 'TE products'. 
FIG. 2.
Steps followed for image analysis from the 3D reconstruction of the CE-nanoCT scan to image processing and noise reduction to final 3D quantification and distribution analysis. (15) phase construct scale fibroin n -micro-CT Table 2 : Categorization and evaluation of X-ray tomography techniques employed for the visualization of features of in vitro 3D engineered tissues (related to bone TE).
